Skip to main content

Table 2 Statistical analysis of changes in Pru p 3 specific IgE and IgG4 levels after Pru p 3 immunotherapy

From: Pru p 3 oral immunotherapy efficacy, induced immunological changes and quality of life improvement in patients with LTP syndrome

 Median (Q1, Q3)p-value
IgEa 06.51 (1.47, 21.70) 
IgE 13.85 (1.08, 10.70) 
IgE 34.69 (1.43, 8.76) 
Dif IgE year 1-basal− 1.12 (− 11.00, 0.17)0.1269
Dif IgE year 3-basal− 1.85 (− 6.90, 0.30)0.0448
IgG4b 00.25 (0.10, 0.34) 
IgG4 11.01 (0.29, 3.37) 
IgG4 30.70 (0.24, 1.75) 
Dif IgG4 year 1-basal0.49 (0.04, 3.27)0.0007
Dif IgG4 year 3-basal0.43 (0.12, 1.30)0.0004
  1. a IgE: KU/l
  2. b IgG: mg/l